SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
+1.17%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$147M
AUM Growth
+$147M
(-2.9%)
Cap. Flow
+$3.39M
Cap. Flow
% of AUM
2.31%
Top 10 Holdings %
Top 10 Hldgs %
90.7%
Holding
22
New
1
Increased
3
Reduced
3
Closed
4
Top Buys
1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$14.7M |
2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$4.84M |
3 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$1.08M |
4 |
Tempest Therapeutics
TPST
|
$1.01M |
Top Sells
1 |
ALLK
Allakos
ALLK
|
$12.6M |
2 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$2.43M |
3 |
Liquidia Corp
LQDA
|
$1.79M |
4 |
RGLS
Regulus Therapeutics
RGLS
|
$1.13M |
5 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$221K |
Sector Composition
1 | Healthcare | 100% |